Mirum Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.86 | $157.41 M | -2.5 | 51 | $0 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.92 | $120.37 M | -1.65 | 384 | $380.79 M |
APLS
Apellis Pharmaceuticals, Inc. |
$33.17 | $4.90 B | -11.77 | 702 | $396.59 M |
ARQT
Arcutis Biotherapeutics, Inc. |
$14.57 | $838.13 M | -2.59 | 296 | $59.61 M |
BPMC
Blueprint Medicines Corporation |
$87.16 | $6.47 B | -21.48 | 638 | $249.38 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.70 | $1.12 B | -5.11 | 174 | $0 |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
IMCR
Immunocore Holdings plc |
$29.84 | $2.08 B | -26.72 | 497 | $249.43 M |
INZY
Inozyme Pharma, Inc. |
$2.84 | $286.39 M | -3.43 | 59 | $0 |
KALV
KalVista Pharmaceuticals, Inc. |
$8.85 | $492.76 M | -3.74 | 150 | $0 |
LRMR
Larimar Therapeutics, Inc. |
$4.01 | $611.84 M | -9.99 | 42 | $0 |
LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
MLTX
MoonLake Immunotherapeutics |
$53.54 | $2.62 B | -57.88 | 50 | $0 |
TERN
Terns Pharmaceuticals, Inc. |
$5.67 | $462.44 M | -5.67 | 66 | $0 |
VECT
VectivBio Holding AG |
$16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
XFOR
X4 Pharmaceuticals, Inc. |
$0.75 | $169.62 M | -1.51 | 127 | $0 |